TMS for depression with long COVID
Part of Brain & nervous system, Infections, Lungs & breathing, Mental health clinical trials.
This trial tests whether accelerated TMS (a brain stimulation treatment) can help people with depression who also have long COVID. It may be an option if your depression hasn't improved enough with medication alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have depression that is at least moderate (score of 20 or higher on a standard questionnaire).
- You have been diagnosed with post-COVID-19 condition (long COVID).
- Your depression has not improved enough with medication, and you've been on a stable dose for at least 4 weeks.
- You are not pregnant or breastfeeding, and do not plan to become pregnant during the trial.
- You do not have metal in your head, a pacemaker, a history of seizures, or certain other medical conditions that make TMS unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether intermittent theta burst stimulation (a type of brain stimulation using a magnetic device) can help keep depression from coming back after it has improved. It focuses on people whose depression has responded to an earlier iTBS treatment and who are able to safely receive TMS.
This study tests if repetitive transcranial magnetic stimulation (rTMS), a non-invasive brain stimulation technique, can help people aged 18 to 65 who have ongoing depression or low mood for more than 12 weeks after a confirmed COVID-19 infection. The treatment uses magnetic pulses to gently stimulate parts of the brain involved in mood regulation.
This trial tests an accelerated form of TMS (a treatment that uses magnetic pulses to stimulate the brain) for people with severe depression who have recently been in a psychiatric hospital. It aims to see if a faster schedule of TMS can help improve symptoms quickly.
This trial studies a non-invasive brain stimulation treatment for people with depression or related symptoms that haven't improved with standard treatments. The goal is to see how well it works in real-world settings.
This trial tests a faster version of a brain stimulation treatment called TMS for people with depression. The goal is to see how well it works and how tolerable it is.
This study tests an accelerated form of iTBS (a non-invasive brain stimulation technique) for depression that hasn't improved with antidepressant medications. The goal is to help people with major depression who haven't responded adequately to at least one antidepressant drug.
Hear when a new Depressive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.